7CI Stock Overview
Operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Cronos Group Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$1.87 |
52 Week High | CA$3.10 |
52 Week Low | CA$1.66 |
Beta | 1.01 |
11 Month Change | -5.13% |
3 Month Change | -11.31% |
1 Year Change | 0.11% |
33 Year Change | -56.01% |
5 Year Change | -69.90% |
Change since IPO | -17.51% |
Recent News & Updates
Recent updates
Shareholder Returns
7CI | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -10.6% | -7.0% | -0.4% |
1Y | 0.1% | -21.6% | 7.1% |
Return vs Industry: 7CI exceeded the German Pharmaceuticals industry which returned -22.4% over the past year.
Return vs Market: 7CI underperformed the German Market which returned 7.8% over the past year.
Price Volatility
7CI volatility | |
---|---|
7CI Average Weekly Movement | 7.3% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7CI's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7CI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 356 | Mike Gorenstein | www.thecronosgroup.com |
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Cronos Group Inc. Fundamentals Summary
7CI fundamental statistics | |
---|---|
Market cap | €734.21m |
Earnings (TTM) | -€45.13m |
Revenue (TTM) | €105.53m |
6.9x
P/S Ratio-16.0x
P/E RatioIs 7CI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7CI income statement (TTM) | |
---|---|
Revenue | US$111.23m |
Cost of Revenue | US$87.81m |
Gross Profit | US$23.42m |
Other Expenses | US$70.98m |
Earnings | -US$47.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.12 |
Gross Margin | 21.06% |
Net Profit Margin | -42.76% |
Debt/Equity Ratio | 0% |
How did 7CI perform over the long term?
See historical performance and comparison